KR20070000508A - 화학적 방법 및 결정형 - Google Patents

화학적 방법 및 결정형 Download PDF

Info

Publication number
KR20070000508A
KR20070000508A KR1020067023008A KR20067023008A KR20070000508A KR 20070000508 A KR20070000508 A KR 20070000508A KR 1020067023008 A KR1020067023008 A KR 1020067023008A KR 20067023008 A KR20067023008 A KR 20067023008A KR 20070000508 A KR20070000508 A KR 20070000508A
Authority
KR
South Korea
Prior art keywords
formula
compound
monohydrochloride
crystalline
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067023008A
Other languages
English (en)
Korean (ko)
Other versions
KR20060136478A (ko
Inventor
다렌 마이클 카인
이안 레오나르드 파터노스터
피터 데이비드 펜버티 샤플랜드
Original Assignee
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20070000508(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0407521A external-priority patent/GB0407521D0/en
Priority claimed from GB0411688A external-priority patent/GB0411688D0/en
Application filed by 글락소 그룹 리미티드 filed Critical 글락소 그룹 리미티드
Publication of KR20060136478A publication Critical patent/KR20060136478A/ko
Publication of KR20070000508A publication Critical patent/KR20070000508A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
KR1020067023008A 2004-04-02 2005-03-30 화학적 방법 및 결정형 Withdrawn KR20070000508A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0407521A GB0407521D0 (en) 2004-04-02 2004-04-02 Chemical process
GB0407521.4 2004-04-02
GB0411688.5 2004-05-25
GB0411688A GB0411688D0 (en) 2004-05-25 2004-05-25 Chemical process
US57446704P 2004-05-26 2004-05-26
US60/574,467 2004-05-26

Publications (2)

Publication Number Publication Date
KR20060136478A KR20060136478A (ko) 2007-01-02
KR20070000508A true KR20070000508A (ko) 2007-01-02

Family

ID=34963396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067023008A Withdrawn KR20070000508A (ko) 2004-04-02 2005-03-30 화학적 방법 및 결정형

Country Status (14)

Country Link
US (1) US7846973B2 (cg-RX-API-DMAC7.html)
EP (1) EP1730104A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007530652A (cg-RX-API-DMAC7.html)
KR (1) KR20070000508A (cg-RX-API-DMAC7.html)
AR (1) AR052301A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005227733A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509382A (cg-RX-API-DMAC7.html)
CA (1) CA2561400A1 (cg-RX-API-DMAC7.html)
IL (1) IL178064A0 (cg-RX-API-DMAC7.html)
MA (1) MA28558B1 (cg-RX-API-DMAC7.html)
NO (1) NO20064884L (cg-RX-API-DMAC7.html)
PE (1) PE20060678A1 (cg-RX-API-DMAC7.html)
TW (1) TW200536814A (cg-RX-API-DMAC7.html)
WO (1) WO2005095328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
JP5584138B2 (ja) 2008-01-11 2014-09-03 ノバルティス アーゲー キナーゼ阻害剤としてのピリミジン類
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
IT1399912B1 (it) * 2010-04-29 2013-05-09 Lundbeck Pharmaceuticals Italy S Pa Processo di preparazione di ritodrina cloridrato.
JP5645762B2 (ja) * 2010-06-29 2014-12-24 日本ポリプロ株式会社 ポリオレフィンの結晶性分布分析方法およびその装置
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
GB201212081D0 (en) * 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
US4353656A (en) * 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
EP0069715B1 (en) 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
FI944549L (fi) * 1992-04-02 1994-11-30 Smithkline Beecham Corp Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
US5495054A (en) * 1994-05-31 1996-02-27 Sepracor, Inc. Tetrahydroindeno[1,2-D][1,3,2]oxazaboroles and their use as enantioselective catalysts
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
GB9700226D0 (en) * 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
OA11558A (en) 1999-12-08 2004-06-03 Advanced Medicine Inc Beta 2-adrenergic receptor agonists.
UA73965C2 (en) * 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
US6632666B2 (en) * 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
AR040661A1 (es) * 2002-07-26 2005-04-13 Theravance Inc Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
BR0314392A (pt) 2002-09-16 2005-07-12 Glaxo Group Ltd Composto ou um sal do mesmo, composição farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de uma doença inflamatória e/ou alérgica ou deficiência cognitiva em um mamìfero, e, combinação
TW200510277A (en) 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist

Also Published As

Publication number Publication date
JP2007530652A (ja) 2007-11-01
CA2561400A1 (en) 2005-10-13
WO2005095328A1 (en) 2005-10-13
BRPI0509382A (pt) 2007-09-18
IL178064A0 (en) 2006-12-31
EP1730104A1 (en) 2006-12-13
NO20064884L (no) 2006-10-26
MA28558B1 (fr) 2007-04-03
AR052301A1 (es) 2007-03-14
US7846973B2 (en) 2010-12-07
US20100063157A1 (en) 2010-03-11
TW200536814A (en) 2005-11-16
PE20060678A1 (es) 2006-08-02
AU2005227733A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
US7317040B2 (en) Nitric oxide synthase inhibitor phosphate salt
KR101064787B1 (ko) 아민 유도체
KR20060017616A (ko) 결정형 β2 아드레날린 수용체 작용제
WO2003042160A1 (en) Aryl aniline beta-2 adrenergic receptor agonists
EA003026B1 (ru) Ингибиторы синтазы оксида азота
CN1671650A (zh) 结晶β2肾上腺素能受体激动剂
KR20060136478A (ko) 화학적 방법 및 결정형
US7846973B2 (en) Chemical process and new crystalline form
US7772250B2 (en) Compounds
JPH03133946A (ja) フェンエタノールアミン化合物
US8236959B2 (en) Process for preparing isomers of carmoterol
JP5468543B2 (ja) アセトアミド立体異性体
JP2008546659A (ja) ベータ2−アドレナリン作動薬であるキノリン−2−オン誘導体の新規な塩の形態
CA2084162A1 (en) Quinolylmethoxyphenyl-acetamides
TW200942230A (en) 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
ZA200608096B (en) Chemical process and new crystalling form
JPH05117236A (ja) ジクロロアニリン化合物
MXPA06011239A (en) Chemical process and new crystalline form
HK1128681A (en) Amine derivatives
MXPA06008311A (en) Sulfonamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061102

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid